Mutation tracking in circulating tumor DNA predicts relapse in early breast cancer (Q48655131)

13 February 2018

title

Mutation tracking in circulating tumor DNA predicts relapse in early breast cancer (English)

1 reference

13 February 2018

author

Maggie Chon U Cheang

7

1 reference

13 February 2018

Jorge Reis-Filho

13

object named as

Jorge S Reis-Filho

1 reference

13 February 2018

Mitch Dowsett

12

0 references

Britta Weigelt

3

object named as

Britta Weigelt

1 reference

13 February 2018

Iwanka Kozarewa

10

object named as

Iwanka Kozarewa

1 reference

13 February 2018

author name string

Isaac Garcia-Murillas

1

1 reference

13 February 2018

Gaia Schiavon

2

1 reference

13 February 2018

Charlotte Ng

4

1 reference

13 February 2018

Sarah Hrebien

5

1 reference

13 February 2018

Rosalind J Cutts

6

1 reference

13 February 2018

Peter Osin

8

1 reference

13 February 2018

Ashutosh Nerurkar

9

1 reference

13 February 2018

Javier Armisen Garrido

11

1 reference

13 February 2018

Ian E Smith

14

1 reference

13 February 2018

Nicholas C Turner

15

1 reference

13 February 2018

language of work or name

English

0 references

publication date

1 August 2015

1 reference

13 February 2018

Science Translational Medicine

published in

1 reference

13 February 2018

volume

7

1 reference

13 February 2018

issue

302

1 reference

13 February 2018

page(s)

302ra133

1 reference

13 February 2018

cites work

Global cancer statistics

1 reference

https://api.crossref.org/works/10.1126/SCITRANSLMED.AAB0021

US incidence of breast cancer subtypes defined by joint hormone receptor and HER2 status

21 January 2018

1 reference

https://api.crossref.org/works/10.1126/SCITRANSLMED.AAB0021

Noninvasive identification and monitoring of cancer mutations by targeted deep sequencing of plasma DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126/SCITRANSLMED.AAB0021

Analysis of circulating tumor DNA to monitor metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1126/SCITRANSLMED.AAB0021

Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1126/SCITRANSLMED.AAB0021

Noninvasive detection of HER2 amplification with plasma DNA digital PCR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126/SCITRANSLMED.AAB0021

Detection of cancer DNA in plasma of patients with early-stage breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126/SCITRANSLMED.AAB0021

Detection of circulating tumor DNA in early- and late-stage human malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1126/SCITRANSLMED.AAB0021

Circulating mutant DNA to assess tumor dynamics

21 January 2018

1 reference

https://api.crossref.org/works/10.1126/SCITRANSLMED.AAB0021

Analysis of circulating tumour DNA to monitor disease burden following colorectal cancer surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126/SCITRANSLMED.AAB0021

21 January 2018

1 reference

https://api.crossref.org/works/10.1126/SCITRANSLMED.AAB0021

High-throughput droplet digital PCR system for absolute quantitation of DNA copy number

21 January 2018

1 reference

https://api.crossref.org/works/10.1126/SCITRANSLMED.AAB0021

The clonal and mutational evolution spectrum of primary triple-negative breast cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1126/SCITRANSLMED.AAB0021

Tumour evolution inferred by single-cell sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1126/SCITRANSLMED.AAB0021

The life history of 21 breast cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1126/SCITRANSLMED.AAB0021

Characterization of the genomic features and expressed fusion genes in micropapillary carcinomas of the breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1126/SCITRANSLMED.AAB0021

The thanatophoric dysplasia type II mutation hampers complete maturation of fibroblast growth factor receptor 3 (FGFR3), which activates signal transducer and activator of transcription 1 (STAT1) from the endoplasmic reticulum

21 January 2018

1 reference

https://api.crossref.org/works/10.1126/SCITRANSLMED.AAB0021

Frequent activating mutations of FGFR3 in human bladder and cervix carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126/SCITRANSLMED.AAB0021

Detection and quantification of rare mutations with massively parallel sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1126/SCITRANSLMED.AAB0021

Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1126/SCITRANSLMED.AAB0021

The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1126/SCITRANSLMED.AAB0021

Adjuvant trastuzumab in HER2-positive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1126/SCITRANSLMED.AAB0021

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126/SCITRANSLMED.AAB0021

Detecting biomarkers with microdroplet technology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126/SCITRANSLMED.AAB0021

Detecting somatic genetic alterations in tumor specimens by exon capture and massively parallel sequencing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126/SCITRANSLMED.AAB0021

Establishing the origin of metastatic deposits in the setting of multiple primary malignancies: the role of massively parallel sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1126/SCITRANSLMED.AAB0021

Prognosis of women with metastatic breast cancer by HER2 status and trastuzumab treatment: an institutional-based review

21 January 2018

1 reference

https://api.crossref.org/works/10.1126/SCITRANSLMED.AAB0021

The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data

21 January 2018

1 reference

https://api.crossref.org/works/10.1126/SCITRANSLMED.AAB0021

The Sequence Alignment/Map format and SAMtools

21 January 2018

1 reference

https://api.crossref.org/works/10.1126/SCITRANSLMED.AAB0021

Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1126/SCITRANSLMED.AAB0021

Strelka: accurate somatic small-variant calling from sequenced tumor-normal sample pairs

21 January 2018

1 reference

https://api.crossref.org/works/10.1126/SCITRANSLMED.AAB0021

VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1126/SCITRANSLMED.AAB0021

Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors

21 January 2018

1 reference

https://api.crossref.org/works/10.1126/SCITRANSLMED.AAB0021

10.1126/SCITRANSLMED.AAB0021

21 January 2018

Identifiers

DOI

1 reference

13 February 2018

1 reference

13 February 2018